NVO
$NVO
Novo Nordisk A/S
Danish pharmaceutical company behind Ozempic and Wegovy.
Healthcare$49.37
-0.20 (-0.40%)
Day Range$48.67 - $49.85
Prev Close$49.57
Analyst Rating
Buy
18 Buy / 13 Hold / 3 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Feb 22
Weekly updates
Latest Report
NVO: Wegovy Growth vs Competition
Novo Nordisk ($NVO) sits at the center of the obesity and diabetes market growth story thanks to Wegovy and Ozempic. Recent product moves, manufacturing plans, and Medicare coverage are strong catalysts, but competition from Eli Lilly and margin/valuation risks deserve attention.
Feb 17, 2026